Trademark Overview
On Monday, November 17, 2025, a trademark application was filed for TRIPLHELIX with the United States Patent and Trademark Office. The USPTO has given the TRIPLHELIX trademark a serial number of 99501136. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, April 28, 2026. This trademark is owned by TriplHelix, Inc.. The TRIPLHELIX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical services, namely, treating medical patients for cancer and autoimmune diseases through biologic and genomic therapies in the fields of reversing biological aging and treating cancer through telomeric attrition, epigenetic and regenerative therapeutics; Medical services, namely, treating medical patients for cancer and autoimmune diseases with biologic and genomic therapies that restore tissue function, enhance immune competence, and promote cell regeneration based on proprietary secretome formulations, encapsulated gene therapies, and cell-based delivery platforms; Medical services, namely, treating medical patients for cancer and autoimmune diseasesith thymic based cell regeneration therapies, secretome-driven rejuvenation therapies, gene therapies, cryoblation and immunotherapy for medical purposes; None of the foregoing for use in the research and data analytics for population health, geneaology, virology, or epidemiology
